Dominik Karres

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.

Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.

Journal: Pharmaceutical medicine

Published: June 18, 2026

Calling for a strategic shift in drug development for childhood cancers.

Calling for a strategic shift in drug development for childhood cancers.

Journal: The Lancet. Child & adolescent health

Published: June 13, 2026

Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.

Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.

Journal: Pharmaceutical medicine

Published: March 24, 2026

Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer.

Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 29, 2025

Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration.

Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 10, 2025

A model structure for describing uncertainties in benefit-risk assessment of oncology drug applications.

A model structure for describing uncertainties in benefit-risk assessment of oncology drug applications.

Journal: Frontiers in medicine

Published: March 07, 2025

New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development.

New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development.

Journal: Frontiers in medicine

Published: February 25, 2025

Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 14, 2024

Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation.

Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation.

Journal: British journal of pharmacology

Published: April 08, 2024

Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer.

Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 23, 2023

Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.

Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 03, 2023

Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.

Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.

Journal: Journal of the National Cancer Institute

Published: August 07, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026